Key points from article :
“We are getting an increasingly sophisticated understanding of what is going on in these diseases” - David Reynolds - chief scientist at Alzheimer’s Research UK.
40 per cent of non-demented individuals had fully fledged Alzheimer’s disease pathology.
ApoE-2 protects against dementia even in people whose brain is full of amyloid.
Inflammation associated with an unbalanced immune response contributes to Alzheimer’s.
Anti-inflammatory medication for arthritis cuts risk of developing dementia by half.
Blood test for amyloid formation came closer last month with a Japanese study.
The study was published in the Alzheimer’s & Dementia: Translational Research & Clinical Interventions.
